beast means that we must proceed with caution when applying genome-wide association (GWA) studies, which are the present 'answer' to complex traits.
Our current, still rather unclear, picture of the genetics of psychiatric conditions is the result of a string of failed or irreproducible attempts at identifying variants using linkage, candidate and association studies. But there are signs that the field has turned a corner -convincingly replicated findings have emerged by incorporating endophenotypes and environmental risk factors into analyses. We also have stricter standards for GWA studies -increasing sample sizes and sharpening phenotypic boundaries should iron out many of the current statistical limitations. Or will it?
As Burmeister and colleagues point out on page 527, the best strategy will be determined by the degree of heterogeneity. If variants are common and each makes only a marginal contribution to risk for any disorder, then GWA studies using vastly larger sample sizes might be fruitful, as was the Reproducible results will be hard won but hugely valuable -perhaps unusually for complex disorders, new biological information is expected to be incorporated quickly into clinical practice, primarily in diagnosis. 
